EPICS Congress Coverage: ASCO GU 2021 Highlights
Expert perspectives and strategic insights on the latest therapeutic developments in genitourinary malignancies.
FACULTY MEMBERS
Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center, VA, US
Karim Fizazi, MD, PhD
Gustave Roussy Institute, Villejuif, France
Leonard Gomella, MD, FACS
Sidney Kimmel Cancer Center, PA, US
Thomas Powles, MD, MBBS, MRCP
Barts Cancer Institute, London, UK
Oliver Sartor, MD
Tulane Cancer Center, LA, US
Manuela Schmidinger, MD
Medical University of Vienna, Vienna, Austria
Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, NY, US
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
A report will be produced based on the meeting, and will discuss the following topics
- Novel Therapies for BCG-Unresponsive NMIBC and MIBC
- Novel Agents for Metastatic Bladder Cancers
- Metastatic Prostate Cancer – Hormonal Therapies and Imaging
- Cytotoxic, Immune, and Targeted Therapies for Metastatic Prostate Cancer
- Advanced Renal Cell Carcinoma
- Renal Cell Carcinoma – Subgroup-Specific Therapies
